BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:BIM • FR0013280286

94.9 EUR
-2.6 (-2.67%)
Last: Feb 6, 2026, 05:29 PM
Fundamental Rating

6

BIM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 68 industry peers in the Health Care Equipment & Supplies industry. BIM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BIM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year BIM was profitable.
  • BIM had a positive operating cash flow in the past year.
  • Each year in the past 5 years BIM has been profitable.
  • Each year in the past 5 years BIM had a positive operating cash flow.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

  • BIM's Return On Assets of 7.04% is amongst the best of the industry. BIM outperforms 80.88% of its industry peers.
  • The Return On Equity of BIM (9.61%) is better than 63.24% of its industry peers.
  • With a decent Return On Invested Capital value of 8.56%, BIM is doing good in the industry, outperforming 73.53% of the companies in the same industry.
  • BIM had an Average Return On Invested Capital over the past 3 years of 10.05%. This is in line with the industry average of 9.62%.
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROIC 8.56%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • BIM has a Profit Margin of 9.17%. This is in the better half of the industry: BIM outperforms 64.71% of its industry peers.
  • In the last couple of years the Profit Margin of BIM has remained more or less at the same level.
  • BIM has a Operating Margin of 12.38%. This is comparable to the rest of the industry: BIM outperforms 54.41% of its industry peers.
  • In the last couple of years the Operating Margin of BIM has grown nicely.
  • BIM has a Gross Margin (56.27%) which is comparable to the rest of the industry.
  • BIM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.38%
PM (TTM) 9.17%
GM 56.27%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • BIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, BIM has about the same amount of shares outstanding.
  • BIM has less shares outstanding than it did 5 years ago.
  • BIM has a better debt/assets ratio than last year.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • BIM has an Altman-Z score of 6.23. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of BIM (6.23) is better than 91.18% of its industry peers.
  • BIM has a debt to FCF ratio of 1.15. This is a very positive value and a sign of high solvency as it would only need 1.15 years to pay back of all of its debts.
  • BIM's Debt to FCF ratio of 1.15 is amongst the best of the industry. BIM outperforms 86.76% of its industry peers.
  • A Debt/Equity ratio of 0.09 indicates that BIM is not too dependend on debt financing.
  • The Debt to Equity ratio of BIM (0.09) is better than 80.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Altman-Z 6.23
ROIC/WACC1.07
WACC8.01%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.27 indicates that BIM has no problem at all paying its short term obligations.
  • BIM has a Current ratio of 2.27. This is in the better half of the industry: BIM outperforms 66.18% of its industry peers.
  • A Quick Ratio of 1.30 indicates that BIM should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.30, BIM is in the better half of the industry, outperforming 60.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.3
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

  • The earnings per share for BIM have decreased by -8.45% in the last year.
  • The Earnings Per Share has been growing by 10.91% on average over the past years. This is quite good.
  • BIM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.28%.
  • Measured over the past years, BIM shows a quite strong growth in Revenue. The Revenue has been growing by 8.27% on average per year.
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%

3.2 Future

  • BIM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.79% yearly.
  • BIM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.72% yearly.
EPS Next Y15.89%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
EPS Next 5Y11.79%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.72%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 24.59, the valuation of BIM can be described as rather expensive.
  • Based on the Price/Earnings ratio, BIM is valued a bit cheaper than the industry average as 63.24% of the companies are valued more expensively.
  • BIM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.92.
  • Based on the Price/Forward Earnings ratio of 18.96, the valuation of BIM can be described as rather expensive.
  • BIM's Price/Forward Earnings ratio is in line with the industry average.
  • BIM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.59
Fwd PE 18.96
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 73.53% of the companies in the same industry are more expensive than BIM, based on the Enterprise Value to EBITDA ratio.
  • 66.18% of the companies in the same industry are more expensive than BIM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.6
EV/EBITDA 11.82
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of BIM may justify a higher PE ratio.
  • BIM's earnings are expected to grow with 13.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.55
PEG (5Y)2.25
EPS Next 2Y13.86%
EPS Next 3Y13.5%

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.92%, BIM is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.03, BIM pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.83, BIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.92%

5.2 History

  • The dividend of BIM is nicely growing with an annual growth rate of 19.40%!
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 28.07% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
  • BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.07%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (2/6/2026, 5:29:48 PM)

94.9

-2.6 (-2.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04
Earnings (Next)02-27
Inst Owners21.47%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap11.23B
Revenue(TTM)4.12B
Net Income(TTM)378.00M
Analysts75.29
Price Target126.39 (33.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.92%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP28.07%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.53%
PT rev (3m)-0.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.48%
EPS NY rev (3m)-3.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.83%
Valuation
Industry RankSector Rank
PE 24.59
Fwd PE 18.96
P/S 2.73
P/FCF 25.6
P/OCF 14.26
P/B 2.86
P/tB 4.02
EV/EBITDA 11.82
EPS(TTM)3.86
EY4.07%
EPS(NY)5
Fwd EY5.27%
FCF(TTM)3.71
FCFY3.91%
OCF(TTM)6.65
OCFY7.01%
SpS34.82
BVpS33.24
TBVpS23.61
PEG (NY)1.55
PEG (5Y)2.25
Graham Number53.73
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROCE 11.7%
ROIC 8.56%
ROICexc 9.38%
ROICexgc 13.1%
OM 12.38%
PM (TTM) 9.17%
GM 56.27%
FCFM 10.65%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexgc growth 3Y-22.62%
ROICexgc growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Debt/EBITDA 0.36
Cap/Depr 73.43%
Cap/Sales 8.46%
Interest Coverage 250
Cash Conversion 79.94%
Profit Quality 116.09%
Current Ratio 2.27
Quick Ratio 1.3
Altman-Z 6.23
F-Score8
WACC8.01%
ROIC/WACC1.07
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
EPS Next Y15.89%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
EPS Next 5Y11.79%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.72%
EBIT growth 1Y-1.73%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year64.69%
EBIT Next 3Y25.44%
EBIT Next 5Y17.89%
FCF growth 1Y133.53%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y66.81%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%

BIOMERIEUX / BIM.PA FAQ

What is the ChartMill fundamental rating of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.


What is the valuation status of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.


What is the profitability of BIM stock?

BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.


Can you provide the financial health for BIM stock?

The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.


How sustainable is the dividend of BIOMERIEUX (BIM.PA) stock?

The dividend rating of BIOMERIEUX (BIM.PA) is 4 / 10 and the dividend payout ratio is 28.07%.